Novacyt Says Covid-19 Contract Dispute with UK Health Department Continues
September 16 2021 - 3:48AM
Dow Jones News
By Sabela Ojea
Novacyt SA said Thursday that it continues to work with its
legal advisers to progress the U.K. Department of Health and Social
Care's dispute over a supply contract.
In April the clinical-diagnostics specialist, which is listed in
France and the U.K., said the parties haven't reached an agreement
to extend the contract for the supply of Covid-19 diagnostic kits
and other products.
The London-listed company also said that the accounting
treatment of the DHSC revenue and costs in the first half doesn't
change its legal position or rights in relation to the dispute.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
September 16, 2021 04:33 ET (08:33 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Novacyt (EU:ALNOV)
Historical Stock Chart
From Oct 2024 to Nov 2024
Novacyt (EU:ALNOV)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Novacyt (Euronext): 0 recent articles
More Novacyt News Articles